Lawson, Elizabeth A.
Article History
First Online: 29 September 2017
Competing interests
: E.A.L. is on the Scientific Advisory Board of OXT Therapeutics, Inc. E.A.L. has a financial interest in OXT Therapeutics, Inc., a company developing an intranasal oxytocin and long-acting analogues of oxytocin to treat obesity and metabolic disease. E.A.L.'s interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflicts-of-interest policy.